IGF2R Polyclonal Antibody

IGF2R Polyclonal Antibody

The IGF2R Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of the insulin-like growth factor 2 receptor (IGF2R) protein. This antibody is produced using a polyclonal approach, ensuring a diverse range of antibodies that recognize multiple epitopes on the IGF2R protein, thus enhancing the accuracy and reliability of experimental results.

The IGF2R protein plays a crucial role in regulating cell growth and development by binding to insulin-like growth factor 2 (IGF2) and preventing its action. Dysregulation of IGF2R has been implicated in various diseases, including cancer, diabetes, and cardiovascular disorders. Therefore, the ability to accurately measure IGF2R protein levels is of utmost importance in understanding the underlying mechanisms of these diseases and developing targeted therapeutic interventions.

This polyclonal antibody has been rigorously validated for its specificity and sensitivity through various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other proteins, ensuring accurate and reliable results. Additionally, this antibody has been optimized for use in multiple sample types, including cell lysates, tissue homogenates, and biological fluids, providing researchers with flexibility in their experimental design.

The IGF2R Polyclonal Antibody is supplied as a liquid formulation, allowing for easy and convenient handling. It is provided in a range of sizes to accommodate different experimental needs. Each batch of antibody undergoes stringent quality control measures to ensure consistency and reproducibility.

In summary, the IGF2R Polyclonal Antibody is a highly specific and sensitive tool that enables researchers to accurately detect and quantify the IGF2R protein. Its versatility, reliability, and rigorous validation make it an indispensable asset in various research areas, including cancer biology, developmental biology, and therapeutic target identification.